You are on your way to the Revvity Omics (formerly PerkinElmer Genomics) Roadmap2Rare landing page!

Sanofi Canada is working in collaboration with Revvity Omics (formerly PerkinElmer Genomics) to offer the Roadmap2Rare Diagnostic Program (R2RDP), a no-charge genetic and biochemical testing program available to Canadian clinicians. This page will direct you to the Revvity Omics website, where you can:

• Review the test requisition forms (TRFs), which contain test descriptions and eligibility criteria
• Order a kit for specimen collection
• Request laboratory coordination of patient self-collection or mobile phlebotomy
• Find detailed R2RDP information
• Contact the Revvity Omics laboratory team